Skip to main content
Top
Published in: AIDS and Behavior 6/2017

Open Access 01-06-2017 | Original Paper

Cognitive Decline in Relation to Psychological Wellbeing and HIV Disease- and Treatment Characteristics in HIV-Infected Patients on cART: A One-Year Follow-Up Study

Authors: Marloes A. M. Janssen, Peter P. Koopmans, Roy P. C. Kessels

Published in: AIDS and Behavior | Issue 6/2017

Login to get access

Abstract

The objectives of the current study were to examine cognitive decline in relation to psychological wellbeing, HIV disease and treatment characteristics and baseline variables over a one-year period of time in a group of HIV-infected patients on long term cART with undetectable viral load in comparison to a HIV-negative control group. Eighty-two of 95 patients and 43 of 55 controls who completed a baseline assessment for the Art-NeCo study underwent a follow-up neuropsychological assessment. A repeated-measure general linear model analysis was performed to compare the performance at follow-up in comparison to baseline between the patients and controls. Reliable change indices were computed as a measure of significant change in cognitive function. Compared to controls, patients overall performed worse on the domain speed of information processing. In the patient group a worse performance at follow-up was present for the verbal fluency domain compared to the controls, in the absence of a baseline group difference. For the executive function domain, no group differences were found at follow-up, but the patients performed worse than the controls at baseline. We found that cognitive decline was related to more frequent use of recreational drugs and a somewhat heightened level of irritability and more somatic complaints at baseline. However, the decliners did not differ from the non-decliners on any of the HIV-related variables.
Literature
1.
go back to reference Heaton RK, Clifford DB, Franklin DR, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER study. Neurology. 2010;75(23):2087–96.CrossRefPubMedPubMedCentral Heaton RK, Clifford DB, Franklin DR, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER study. Neurology. 2010;75(23):2087–96.CrossRefPubMedPubMedCentral
2.
go back to reference Schouten J, Cinque P, Gisslén M, Reiss P, Portegies P. HIV-1 infection and cognitive impairment in the cART era: a review. AIDS. 2011;25(5):561–75.CrossRefPubMed Schouten J, Cinque P, Gisslén M, Reiss P, Portegies P. HIV-1 infection and cognitive impairment in the cART era: a review. AIDS. 2011;25(5):561–75.CrossRefPubMed
3.
4.
go back to reference Tozzi V, Balestra P, Vlassi C, et al. Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. J Acquir Immune Defic Syndr. 2007;45(2):174–82.CrossRefPubMed Tozzi V, Balestra P, Vlassi C, et al. Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. J Acquir Immune Defic Syndr. 2007;45(2):174–82.CrossRefPubMed
5.
go back to reference Janssen MA, Meulenbroek O, Steens SC, et al. Cognitive functioning, wellbeing and brain correlates in HIV-1 infected patients on long-term combination antiretroviral therapy. AIDS. 2015;29(16):2139–48.CrossRefPubMed Janssen MA, Meulenbroek O, Steens SC, et al. Cognitive functioning, wellbeing and brain correlates in HIV-1 infected patients on long-term combination antiretroviral therapy. AIDS. 2015;29(16):2139–48.CrossRefPubMed
6.
go back to reference Cole MA, Margolick JB, Cox C, et al. Longitudinally preserved psychomotor performance in long-term asymptomatic HIV-infected individuals. Neurology. 2007;69(24):2213–20.CrossRefPubMed Cole MA, Margolick JB, Cox C, et al. Longitudinally preserved psychomotor performance in long-term asymptomatic HIV-infected individuals. Neurology. 2007;69(24):2213–20.CrossRefPubMed
7.
go back to reference Robertson K, Smurzynski M, Parsons TD, et al. The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS. 2007;21(14):1915–21.CrossRefPubMed Robertson K, Smurzynski M, Parsons TD, et al. The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS. 2007;21(14):1915–21.CrossRefPubMed
8.
go back to reference Cysique LA, Brew BJ. Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review. Neuropsychol Rev. 2009;19(2):169–85.CrossRefPubMed Cysique LA, Brew BJ. Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review. Neuropsychol Rev. 2009;19(2):169–85.CrossRefPubMed
9.
go back to reference Cysique LA, Letendre SL, Ake C, et al. Incidence and nature of cognitive decline over 1 year among HIV-infected former plasma donors in China. AIDS. 2010;24(7):983–90.CrossRefPubMedPubMedCentral Cysique LA, Letendre SL, Ake C, et al. Incidence and nature of cognitive decline over 1 year among HIV-infected former plasma donors in China. AIDS. 2010;24(7):983–90.CrossRefPubMedPubMedCentral
10.
go back to reference Heaton RK, Franklin DR Jr, Deutsch R, et al. Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study. Clin Infect Dis. 2015;60(3):473–80.CrossRefPubMed Heaton RK, Franklin DR Jr, Deutsch R, et al. Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study. Clin Infect Dis. 2015;60(3):473–80.CrossRefPubMed
11.
go back to reference van den Berg E, Reijmer YD, de Bresser J, et al. A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus. Diabetologia. 2010;53(1):58–65.CrossRefPubMed van den Berg E, Reijmer YD, de Bresser J, et al. A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus. Diabetologia. 2010;53(1):58–65.CrossRefPubMed
12.
go back to reference Chelune GJ, Naugle RI, Lüders H, Sedlak J, Awad IA. Individual change after epilepsy surgery: practice effects and base-rate information. Neuropsychology. 1993;7(1):41–52.CrossRef Chelune GJ, Naugle RI, Lüders H, Sedlak J, Awad IA. Individual change after epilepsy surgery: practice effects and base-rate information. Neuropsychology. 1993;7(1):41–52.CrossRef
13.
go back to reference Maassen GH. The standard error in the Jacobson and Truax reliable change index: the classical approach to the assessment of reliable change. J Int Neuropsychol Soc. 2004;10(6):888–93.PubMed Maassen GH. The standard error in the Jacobson and Truax reliable change index: the classical approach to the assessment of reliable change. J Int Neuropsychol Soc. 2004;10(6):888–93.PubMed
14.
go back to reference Reger M, Welsh R, Razani J, Martin DJ, Boone KB. A meta-analysis of the neuropsychological sequelae of HIV infection. J Int Neuropsychol Soc. 2002;8(3):410–24.CrossRefPubMed Reger M, Welsh R, Razani J, Martin DJ, Boone KB. A meta-analysis of the neuropsychological sequelae of HIV infection. J Int Neuropsychol Soc. 2002;8(3):410–24.CrossRefPubMed
15.
go back to reference Norman LR, Basso M. An update of the review of neuropsychological consequences of HIV and substance abuse: a literature review and implications for treatment and future research. Curr Drug Abuse Rev. 2015;8(1):50–71.CrossRefPubMedPubMedCentral Norman LR, Basso M. An update of the review of neuropsychological consequences of HIV and substance abuse: a literature review and implications for treatment and future research. Curr Drug Abuse Rev. 2015;8(1):50–71.CrossRefPubMedPubMedCentral
16.
go back to reference Castaneda AE, Tuulio-Henriksson A, Marttunen M, Suvisaari J, Lonnqvist J. A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults. J Affect Disord. 2008;106(1–2):1–27.CrossRefPubMed Castaneda AE, Tuulio-Henriksson A, Marttunen M, Suvisaari J, Lonnqvist J. A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults. J Affect Disord. 2008;106(1–2):1–27.CrossRefPubMed
17.
go back to reference Eysenck MW, Payne S, Derakshan N. Trait anxiety, visuospatial processing, and working memory. Cognit Emot. 2005;19(8):1214–28.CrossRef Eysenck MW, Payne S, Derakshan N. Trait anxiety, visuospatial processing, and working memory. Cognit Emot. 2005;19(8):1214–28.CrossRef
19.
go back to reference Becker WB, Thames AD, Woo E, Castellon SA, Hinkin H. Longitudinal change in cognitive function and medication adherence in HIV-infected adults. AIDS Behav. 2011;15:1888–94.CrossRefPubMedPubMedCentral Becker WB, Thames AD, Woo E, Castellon SA, Hinkin H. Longitudinal change in cognitive function and medication adherence in HIV-infected adults. AIDS Behav. 2011;15:1888–94.CrossRefPubMedPubMedCentral
Metadata
Title
Cognitive Decline in Relation to Psychological Wellbeing and HIV Disease- and Treatment Characteristics in HIV-Infected Patients on cART: A One-Year Follow-Up Study
Authors
Marloes A. M. Janssen
Peter P. Koopmans
Roy P. C. Kessels
Publication date
01-06-2017
Publisher
Springer US
Published in
AIDS and Behavior / Issue 6/2017
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-016-1583-7

Other articles of this Issue 6/2017

AIDS and Behavior 6/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.